Clinical Trial Update: Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SA4503 for safety and preliminary efficacy in patients recovering from ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SA4503

Snippet

Sponsor: M's Science Corporation | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED